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Background: β2-microglobulin is a surrogate marker of middle-
molecule uremic toxins and serum β2-microglobulin levels are
associated with all-cause mortality in hemodialysis (HD)
patients.In this study, we investigated the impact of serum β2-
microglobulin levels on cardiovascular and infectious diseases in
chronic HD patients.
Methods: Prevalent HD patients were selected from the Clinical
Research Center registry for End Stage Renal Disease, a multicenter
prospective cohort study on dialysis patients in Korea. Patients were
categorized into three groups by tertiles of serum β2-microglobulin
levels as follows: Tertile 1, β2-microglobulin o23.47 mg/L; Tertile 2,
β2-microglobulin 23.47-32.24 mg/L; Tertile 3, β2-microglobulin
432.24 mg/L. Cox regression analysis was used to calculate the
adjusted hazard ratio (HR) for ﬁrst cardiovascular diseases or
infection related-hospitalizations.
Results: A total of 1,012 prevalent HD patients were included in
this study. The median follow-up period was 24 months. Multi-
variate Cox proportional hazard model showed that highest tertile
had signiﬁcantly increased risk of cardiovascular diseases related-
hospitalizations compared with the lowest tertile (HR: 1.68, 95%
CI: 1.05-2.67). The risk of infection related-hospitalizations was
signiﬁcantly increased in higher tertiles compared with lowest
tertile (Tertile 2; HR 1.66, 95% CI: 1.07-2.58, Tertile 3; 1.88, 95% CI,
1.23-2.88) after adjustment for clinical variables.Conclusions: Our data showed that the serum β2-microglobulin
levels were signiﬁcant predictor of clinical outcome for cardio-
vascular disease or infection in chronic HD patients.
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Purposes: To evaluate the mineral and bone disorders in children
with chronic kidney disease (CKD) stage I to V predialysis.
Methods: Pediatric subcohort of KNOW-CKD (KoreaN cohort
study for Outcome in patients With CKD) enrolled children
(younger than 20 years) with CKD stage I-V (pre-dialysis) from
ﬁve major pediatric nephrology centers in Korea and collected
medical data associated with CKD-mineral and bone disorder.
Results: Total number of 300 patients (male:female¼
199:101) was included in this study. Serum phosphorus (mean
7 standard deviation 4.8970.75, 4.670.83, 4.6370.85, 5.137
1.37, 5.3571.2 from CKD stage I to V, p¼0.0002), ﬁbroblast
growth factor (FGF)-23 (32.29742.04, 41.33741.00, 70.687
121.06, 67.9766.95, 121.747139.36, p¼0.0030) and the preva-
lence of hyperphosphatemia (8.51%, 10.64%, 25.53%, 25.53%,
29.79%, p¼0.010) increased as CKD progressed. Intact parathyr-
oid hormone (iPTH) increased (40.84740.37, 44.13720.2,
78.93765.21, 181.397183.86, 313.857324.95, po0.001) and
serum 1,25D3 level decreased (47.52721.32, 37.43712.26,
36.86725.97, 28.29715.81, 34.11721.34, po0.001) signiﬁ-
cantly as CKD aggravated. Serum iPTH (r¼0.608, po0.0001)
and FGF-23 (r¼0.4943, po0.0001) showed negative correla-
tion whereas 1,25D3 (r¼0.3288, o0.0001) showed positive
correlation with glomerular ﬁltration rate. FGF-23 showed posi-
tive correlation with serum phosphorus (r¼0.3342, po0.0001),
iPTH (r¼0.3214, po0.0001) and proteinuria (r¼0.3609,
po0.0001), and negative correlation with urine phosphorus
(r¼0.2597, p¼0.0006). The prevalence of patients with
increased alkaline phosphatase level increased signiﬁcantly as
CKD progressed (5.66%, 15.09%, 39.62%, 16.98%, 22.64%,
p¼0.042), which was due to increased prevalence of hyperpar-
athyroidism (po0.001). Active form vitamin D (0%, 3.77%, 11.88%,
40.74%, 68.89%, po0.0001), calcium (2.13%, 0%, 9.90%, 4.44%,
Kidney Res Clin Pract 33 (2014) A1–A7A462.22%, po0.0001) and non-calcium phosphorous binders (0%,
0%, 0%, 0%, 13.33%, po0.0001) were prescribed signiﬁcantly
more often in advanced CKD. Calcium x phosphorus was sig-
niﬁcantly increased in advanced CKD (11.59%, 17.39%, 28.26%,
21.01%, 21.74%, p¼0.002).
Conclusion: As CKD progressed, hyperphosphatemia, hyperpar-
athyroidism and 1,25D3 deﬁciency increased, serum FGF-23 level
increased and urinary phosphorus excretion decreased in chil-
dren with CKD stage I to V predialysis.
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Background: Hypokalemia has been suggested to be a risk
factor in peritoneal dialysis (PD). Recently in US, a large perito-
neal dialysis cohort study showed potassium abnormalities
contribute disproportionately to the high death risk in PD
patients. This issue was reviewed in Korean ESRD cohort com-
paring to hemodialysis (HD).
Patients and methods: A nationwide prospective observational
cohort study (CRC-ESRD) was performed between August 2008 and
October 2013. Among them, patients had been selected who checked
serum potassium level at least twice within 18 months. Overall
mortality rate was evaluated as outcome. Patients were divided into
following four groups based on time-averaged potassium level:
Ko3.5, 3.5rKo4.5, 4.5rKo5.5, Z5.5 mg/dL. They were ana-
lyzed to determine association of serum potassium with mortality
using Cox proportional hazard model.
Results: Follow-up data were available for 1,686 patients (HD
62.3%, PD 37.7%). The mean age was 58.2713.9 years, and the
ratio of men to women was 57% to 43%. Overall duration of dialysis
was 1.973.9 years. PD patients signiﬁcantly had lower serum
potassium level comparing to HD patients (po0.001). Serum
potassium was o3.5 mg/dL in 10.7% of PD patients, whereas 2.2%
in HD patients. During the mean 2.2 year follow up period, 142
patients died of mainly cardiac arrest and infection. Univariate
analysis indicated that older age, history of congestive heart failure
or diabetes could be the risk factor for mortality. Multivariate
analysis proved PD patients with o3.5 mg/dL of time-averaged
serum potassium to have all-cause mortality with adjusted hazard
ratio of 2.5 (95% CI, 1.33-4.41) (p¼0.004), whereas, HD patients was
not. Among adjusted variables, PD patients who had diabetes or
congestive heart failure tended to have higher risk of death withadjusted hazard ratio 1.7 (95% CI, 0.99-2.76) and 2.3 (95% CI 1.24-
4.19) respectively.
Conclusion: PD patients with hypokalemia (o3.5 mg/dL) have
higher mortality risk. This study conﬁrmed the previous cohort
study in different ethnic group. Therefore, regardless of ethnicity,
this result could be accepted.
http://dx.doi.org/10.1016/j.krcp.2014.05.022
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Background: The role of HBV and HCV infections in survival among
dialysis patients remains incompletely understood. This study inves-
tigated the prevalence of hepatitis B or C infection and its impact on
survival in Korean patients on maintenance dialysis.
Methods: The study included 3,321 maintenance dialysis patients
who underwent hepatitis B antigen (HBsAg) and HCV antibody (Ab)
testing from amulticenter prospective cohort study in Korea. HBsAg-
positive and HCV Ab-positive patients were matched to hepatitis
virus-negative patients using propensity score by a ratio of one to
two. We compared the survival of HBsAg and HCV Ab-positive
patients to that of hepatitis virus-negative patients.
Results: A total of 221 (6.7%) HBsAg-positive and 108 (3.7%) HCV
Ab-positive patients were enrolled and followed up for mean
23.5713.3 months. Patients with dialysis vintage of Z10 years
showed a signiﬁcantly higher prevalence of HBV and HCV than
patients with dialysis vintage of o1 year (HBV 10.2% vs. 5.6%,
p¼0.011 and HCV 7.5% vs. 3.3%, p¼0.003, respectively). After
propensity score matching, the cumulative survival was not
different between HBsAg-positive and hepatitis virus-negative
patients (p¼0.370). However, HCV Ab-positive patients showed
